David M. Denton - May 31, 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chief Financial Officer & EVP
Signature
Susan E. Grant, by power of atty., for David M. Denton
Stock symbol
PFE
Transactions as of
May 31, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 05:50 PM
Previous filing
May 9, 2022
Next filing
Nov 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Award $0 +61.3K +6884.83% $0.00 62.2K May 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +80.7K $0.00 80.7K May 31, 2022 Common Stock 80.7K $53.04 Direct F2
transaction PFE Stock Appreciation Rights Award $0 +70.3K $0.00 70.3K May 31, 2022 Common Stock 70.3K $53.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.